Stage IVA Oral Cavity Squamous Cell Carcinoma

8 clinical trials · Condition

Record	Firm	Date
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911)	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	2017-11-13
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer (NCT02827838)	Wake Forest University Health Sciences	2017-01-01
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932)	Case Comprehensive Cancer Center	2015-03-03
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT01267240)	National Cancer Institute (NCI)	2010-12-01
TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma (NCT01542931)	Shanghai Jiao Tong University School of Medicine	2008-01-01
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. (NCT01469429)	Ohio State University Comprehensive Cancer Center	2007-09-04

Every clearance here is in the API, with alerts when new ones post.